全文获取类型
收费全文 | 1331篇 |
免费 | 92篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 108篇 |
妇产科学 | 18篇 |
基础医学 | 176篇 |
口腔科学 | 30篇 |
临床医学 | 150篇 |
内科学 | 264篇 |
皮肤病学 | 17篇 |
神经病学 | 77篇 |
特种医学 | 131篇 |
外科学 | 123篇 |
综合类 | 25篇 |
预防医学 | 74篇 |
眼科学 | 10篇 |
药学 | 167篇 |
中国医学 | 4篇 |
肿瘤学 | 82篇 |
出版年
2021年 | 20篇 |
2019年 | 7篇 |
2018年 | 23篇 |
2017年 | 12篇 |
2016年 | 10篇 |
2015年 | 18篇 |
2014年 | 43篇 |
2013年 | 53篇 |
2012年 | 39篇 |
2011年 | 39篇 |
2010年 | 43篇 |
2009年 | 54篇 |
2008年 | 41篇 |
2007年 | 62篇 |
2006年 | 46篇 |
2005年 | 43篇 |
2004年 | 52篇 |
2003年 | 49篇 |
2002年 | 44篇 |
2001年 | 28篇 |
2000年 | 35篇 |
1999年 | 34篇 |
1998年 | 40篇 |
1997年 | 38篇 |
1996年 | 37篇 |
1995年 | 31篇 |
1994年 | 44篇 |
1993年 | 23篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 21篇 |
1989年 | 33篇 |
1988年 | 37篇 |
1987年 | 24篇 |
1986年 | 33篇 |
1985年 | 19篇 |
1984年 | 23篇 |
1983年 | 20篇 |
1982年 | 19篇 |
1981年 | 24篇 |
1980年 | 16篇 |
1979年 | 9篇 |
1978年 | 11篇 |
1976年 | 16篇 |
1975年 | 14篇 |
1974年 | 12篇 |
1972年 | 7篇 |
1971年 | 10篇 |
1970年 | 9篇 |
1967年 | 10篇 |
排序方式: 共有1459条查询结果,搜索用时 31 毫秒
121.
Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers 下载免费PDF全文
Justesen US Klitgaard NA Brosen K Pedersen C 《British journal of clinical pharmacology》2003,55(1):100-106
AIMS: To evaluate the safety and the pharmacokinetic interaction between amprenavir and delavirdine after multiple dose administration in healthy volunteers. METHODS: This was a prospective, open-label, randomized, controlled, two-sequence, two-period multiple dose study with 18 healthy subjects. Volunteers were randomly assigned to amprenavir, 600 mg twice a day, or delavirdine, 600 mg twice a day, for 10 days, followed by both drugs for another 10 days with pharmacokinetic evaluation on day 10 and day 20. Adverse events were recorded throughout the study. RESULTS: Amprenavir decreased all the delavirdine pharmacokinetic parameters apart from tmax. Delavirdine C12h dropped from 7,916 to 933 ng ml-1 (median decrease 5,930 ng ml-1, 95% CI 3,013, 8,955 ng ml-1). A decrease in amprenavir t(1/2) was also seen leading to almost identical median amprenavir C24h values. No serious clinical adverse events were observed during the study. The most frequently reported effects were gastrointestinal symptoms, headache, fatigue and rash. CONCLUSIONS: Amprenavir is an effective inducer of delavirdine metabolism, probably through its effect on hepatic CYP3A4. This could have consequences in other drug-drug interaction situations. Delavirdine is an inhibitor of amprenavir metabolism. The regimen of amprenavir 600 mg and delavirdine 600 mg twice a day is not recommended when an antiretroviral effect from delavirdine is required. 相似文献
122.
Fulminant hepatic failure (FHF) is an important cause of death worldwide. Despite significant improvements in critical care therapy there has been little impact on survival with mortality rates approaching 80%. In many patients the cause of the liver failure is reversible and if short-term hepatic support is provided, the liver may regenerate. Survivors recover full liver function and a normal life expectancy. For many years the only curative treatment for this condition has been liver transplantation, subjecting many patients to replacement of a potentially self-regenerating organ, with the lifetime danger of immunosuppression and its attendant complications, such as malignancy. Because of the shortage of livers available for transplantation, many patients die before a transplant can be performed, or are too ill for operation by the time a liver becomes available. Many patients with hepatic failure do not qualify for liver transplantation because of concomitant infection, metastatic cancer, active alcoholism or concurrent medical problems. The survival of patients excluded from liver transplantation or those with potentially reversible acute hepatitis might be improved with temporary artificial liver support. With a view to this, bioartificial liver support devices have been developed which replace the synthetic, metabolic and detoxification functions of the liver. Some such devices have been evaluated in clinical trials. During the last decade, improvements in bioengineering techniques have been used to refine the membranes and hepatocyte attachment systems used in these devices, in the hope of improving function. The present article reviews the history of liver support systems, the attendant problems encountered, and summarizes the main systems that are currently under evaluation. 相似文献
123.
A number of neurotransmitters, including acetylcholine, serotonin, noradrenaline, and dopamine, modulate cerebral perfusion. In vascular dementia, reductions in markers of cholinergic innervation are consistently reported, and there are some indications that the serotonergic and dopaminergic systems may also be affected. Limited data indicate that the numbers of nucleus basalis, locus coeruleus, and dorsal raphé neurons and the density of neurotransmitter receptors are not reduced in the majority of cases. These data suggest neurotransmitter systems as a potential therapeutic target in vascular dementia. 相似文献
124.
Court Pedersen M.D. Sc.D. Tiina Petaja M.D. Gitte Strauss M.D. Hans C. Rumke M.D. Airi Poder M.D. Jan Hendrik Richardus M.D. Ph.D. Bart Spiessens Ph.D. Dominique Descamps M.D. Karin Hardt Ph.D. Matti Lehtinen M.D. Ph.D. Gary Dubin M.D. HPV Vaccine Adolescent Study Investigators Network 《The Journal of adolescent health》2007,40(6):564-571
PurposeIn female individuals 15–25-years of age, the AS04-containing human papillomavirus (HPV)–16/18 vaccine is highly immunogenic and provides up to 100% protection against HPV-16/18 persistent infection and associated cervical lesions up to 4.5 years. Optimal cervical cancer prevention will require prophylactic vaccination against oncogenic HPV 16 and 18 before the onset of sexual activity in early adolescent girls. To establish the feasibility of vaccination in girls 10–14 years of age, we compared the immunogenicity and safety in early adolescent female individuals to those 15–25 years in whom vaccine efficacy has been demonstrated.MethodsWe enrolled 773 female participants aged 10–14 years and 15–25 years to receive the HPV-16/18 L1 VLP AS04 vaccine, which was administered at months 0, 1, and 6. Serum samples were collected at months 0 and 7; antibodies to HPV 16 and 18 VLPs were measured by enzyme-linked immunosorbent assay. Vaccine safety was assessed at 7 or 30 days after each dose; serious adverse events were recorded during the entire study period.ResultsBoth age groups achieved 100% seroconversion for HPV 16 and 18. Participants in the group aged 10–14 years were not only noninferior to those 15–25 years in terms of HPV 16 and 18 seroconversion rates but also had approximately twice as high geometric mean titers. The vaccine was generally safe and well tolerated.ConclusionsThese findings suggest that HPV vaccination during early adolescence is generally safe, well tolerated, and highly immunogenic. The observed higher antibody titers in the group 10–14 years of age are likely to result in longer antibody persistence. Overall, these data support the implementation of prophylactic HPV vaccination in this age group. 相似文献
125.
PR Hunziker S Smith M Scherrer-Crosbie N Liel-Cohen RA Levine R Nesbitt SA Benton MH Picard 《Circulation》1999,99(5):1-6
Background--Currently, the reporting and archiving of echocardiographic data suffer from the difficulty of representing heart motion on printable 2-dimensional (2D) media. Methods and Results--We studied the capability of holography to integrate motion into 2D echocardiographic prints. Images of normal human hearts and of a variety of mitral valve function abnormalities (mitral valve prolapse, systolic anterior motion of the mitral leaflets, and obstruction of the mitral valve by a myxoma) were acquired digitally on standard echocardiographic machines. Images were processed into a data format suitable for holographic printing. Angularly multiplexed holograms were then printed on a prototype holographic "laser" printer, with integration of time in vertical parallax, so that heart motion became visible when the hologram was tilted up and down. The resulting holograms displayed the anatomy with the same resolution as the original acquisition and allowed detailed study of valve motion with side-by-side comparison of normal and abnormal findings. Comparison of standard echocardiographic measurements in original echo frames and corresponding hologram views showed an excellent correlation of both methods (P<0.0001, r2=0.979, mean bias=2.76 mm). In this feasibility study, both 2D and 3D holographic images were produced. The equipment needed to view these holograms consists of only a simple point-light source. Conclusions--Holographic representation of myocardial and valve motion from echocardiographic data is feasible and allows the printing on a 2D medium of the complete heart cycle. Combined with the recent development of online holographic printing, this novel technique has the potential to improve reporting, visualization, and archiving of echocardiographic imaging. 相似文献
126.
Age, sex, and estimated time of onset of insulin-dependent diabetes were determined for children in Pittsburgh (N = 673), Gainesville (N = 976), Galveston (n = 741), and Melbourne (N = 851). The US cities had a decrease in new cases during the summer and peak incidence in January through April. In Melbourne, monthly trends were reversed: there were more cases during May through August. In US cities, but not in Melbourne, children less than 6 years old showed a greater variation by season than children 6 years old and older. Observations of the same fall and winter onset (in different calendar months) of insulin-dependent diabetes in Australia and the United States, and exaggeration of seasonal differences in young US children, suggest that onset of insulin-dependent diabetes is associated with seasonally varying viral diseases. Mumps and rubella infections do not seem to be responsible for much of the seasonal variation. Seasonal peaks of mumps and rubella are later than those observed for insulin-dependent diabetes, and immunization with live mumps and rubella viruses has not been associated with changes in incidence of insulin-dependent diabetes. An increase in disease incidence in boys over girls below age 6 years and in girls over boys at ages 6 through 11 years was consistently observed but not explained. 相似文献
127.
Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease 总被引:6,自引:0,他引:6
Martin-Ruiz CM Piggott M Gotti C Lindstrom J Mendelow AD Siddique MS Perry RH Perry EK Court JA 《Neuropharmacology》2000,39(13):119-2839
It is well established that nicotinic receptors in the mammalian striatum are involved in modulation of the release of several neurotransmitters, including dopamine. In addition, nicotinic receptors with high affinity for agonists have generally been found to be reduced in the striatum in Parkinson's disease. In the present study antibodies have been used to examine which subunits contribute to the striatal nicotinic receptor loss in Parkinson's disease, and whether the reduction in [3H]nicotine binding correlates with synaptic loss. Autopsy tissue from the putamen of 12 Parkinson's disease cases and 12 age-matched control subjects was analysed by immunoblotting using antibodies against recombinant peptides specific for 3, 4, 7, β2 and β4 nicotinic acetylcholine receptor (nAChR) subunits and the synaptic marker synaptophysin, in conjunction with assessment of [3H]nicotine binding by autoradiography. The data indicate that there is no loss of 3, 4, 7 and β2 immunoreactivity in the putamen in Parkinson's disease, despite a highly significant reduction in [3H]nicotine binding. An intense signal of β4 immunoreactivity was found in human dorsal root ganglia, but not in temporal cortex or putamen samples. Synaptophysin immunoreactivities were also similar in Parkinson's disease and control cases. These results suggest that the loss of nicotine binding in the putamen in Parkinson's disease may involve an nAChR subunit (e.g., 5 and/or 6) other than those investigated. Alternatively, the results could reflect impaired subunit assembly at the plasma membrane. 相似文献
128.
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases 总被引:13,自引:0,他引:13
Perry E Martin-Ruiz C Lee M Griffiths M Johnson M Piggott M Haroutunian V Buxbaum JD Nãsland J Davis K Gotti C Clementi F Tzartos S Cohen O Soreq H Jaros E Perry R Ballard C McKeith I Court J 《European journal of pharmacology》2000,393(1-3):215-222
Human brain ageing is associated with reductions in a variety of nicotinic receptors subtypes, whereas changes in age-related disorders including Alzheimer's disease or Parkinson's disease are more selective. In Alzheimer's disease, in the cortex there is a selective loss of the alpha4 (but not alpha3 or 7) subunit immunoreactivity and of nicotine or epibatidine binding but not alpha-bungarotoxin binding. Epibatidine binding is inversely correlated with clinical dementia ratings and with the level of Abeta1-42, but not related to plaque or tangle densities. In contrast, alpha-bungarotoxin binding is positively correlated with plaque densities in the entorhinal cortex. In human temporal cortex loss of acetylcholinesterase catalytic activity is positively correlated with decreased epibatidine binding and in a transgenic mouse model over expressing acetylcholinesterase, epibatidine binding is elevated. In Parkinson's disease, loss of striatal nicotine binding appears to occur early but is not associated with a loss of alpha4 subunit immunoreactivity. Tobacco use in normal elderly individuals is associated with increased alpha4 immunoreactivity in the cortex and lower densities of amyloid-beta plaques, and with greater numbers of dopaminergic neurons in the substantia nigra pars compacta. These findings indicate an early involvement of the alpha4 subunit in beta-amyloidosis but not in nigro-striatal dopaminergic degeneration. 相似文献
129.
130.
Electrolytic lesions of the fimbria/fornix in 26-month-old rats led to an enhanced phosphoinositide (PI) hydrolysis in response to carbachol in hippocampal slices, 11-15 days after surgery. The lesions caused a 78% reduction of choline acetyltransferase but no change in muscarinic binding. The PI response to carbachol and the enhancement of this after lesioning were not as great as that previously reported in young adult rats. 相似文献